Skip to main content
Metro Brands Limited logo

Metro Brands Limited — Investor Relations & Filings

Ticker · METROBRAND ISIN · INE317I01021 LEI · 894500HOIH518O40VN09 BSE.NS Wholesale and retail trade
Filings indexed 972 across all filing types
Latest filing 2022-11-23 Regulatory Filings
Country IN India
Listing BSE.NS METROBRAND

About Metro Brands Limited

https://metrobrands.com/

Metro Brands Limited operates an extensive portfolio of footwear and accessory brands, including Metro, Mochi, Walkway, and Da Vinchi. The company provides a comprehensive range of products for men, women, and children across various price points, from economy to premium segments. Beyond its proprietary labels, the organization maintains strategic licensing and distribution agreements with international brands such as Crocs, FitFlop, and Fila. The business model integrates a multi-channel distribution network consisting of exclusive brand outlets, multi-brand outlets, and digital commerce platforms. Key operations focus on product design, sourcing, and retail management, supported by a centralized supply chain designed to meet diverse consumer preferences in the footwear and lifestyle accessories market.

Recent filings

Filing Released Lang Actions
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice dated November 23, 2022, informing stock exchanges about the schedule of upcoming analyst and institutional investor meetings. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which mandates timely disclosure of material events. The document does not contain any financial data, results, or detailed reports but merely announces the schedule of investor meetings. The length is about 4014 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is an announcement related to investor meetings, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like Investor Presentation or Earnings Release.
2022-11-23 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the outcome of an analyst/institutional investor meeting. It references compliance with SEBI Listing Obligations Regulation 30, which pertains to disclosure of material events. The content is a brief announcement of a meeting held on November 22, 2022, with no financial data, no detailed report, and no indication of a full report being attached or published. The document is under 5,000 characters and serves as a regulatory announcement of an event rather than a financial report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-11-23 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about a change in the schedule of an Analyst/Institutional Investor meeting. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about scheduling and notifying a meeting with investors, not the meeting materials or financial results themselves. The document length is short (1785 characters), and it does not contain financial data or detailed presentations. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about an investor meeting schedule change, not a report or presentation.
2022-11-22 English
Insider Trading - Others
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges reporting a violation of the company's Code of Conduct for Prohibition of Insider Trading, referencing SEBI regulations and circulars. It includes detailed information about the violation, the designated person involved, the nature of the violation, and the action taken by the company. The document is a regulatory compliance report related to insider trading violations, not a financial report, earnings release, or management discussion. It is not an announcement of a report publication but a formal regulatory filing to stock exchanges as required by SEBI. Therefore, it fits best under Regulatory Filings (RNS). The document length (10,844 characters) and content confirm it is a substantive regulatory filing rather than a brief announcement or certification.
2022-11-22 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing them about the schedule of an upcoming Analyst/Institutional Investor meeting. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an intimation or announcement of a meeting schedule, not the meeting transcript or presentation itself. The document length is short (1831 characters), and it does not contain any financial data, analysis, or detailed presentation. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about an investor meeting schedule and does not fit other more specific categories like Investor Presentation or Call Transcript.
2022-11-21 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, reporting the outcome of an analyst/institutional investor meeting held on November 17, 2022. It is a brief announcement informing the stock exchanges about the investor meeting details and does not contain any financial statements, detailed financial analysis, or report content. The document length is short (1612 characters), and it serves as a regulatory announcement rather than a full report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-11-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.